The combination of CXCL5 antibody, 1400 W or GM-CSF antibody with anti-PD-L1mAb resulted in increased number of T cells in primary tumour sites (Supplementary Fig. 5D, F). The gene discussed is CXCL5; the disease is neoplasm.